List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 98 studies with search of: Open Studies | "Breast Neoplasms, Male"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Not yet recruiting PD 0332991 in Treating Patients With Refractory Solid Tumors
Conditions: Adult Solid Tumor;   Adenocarcinoma of the Colon;   Adenocarcinoma of the Rectum;   Adult Central Nervous System Germ Cell Tumor;   Adult Teratoma;   Benign Teratoma;   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   Familial Testicular Germ Cell Tumor;   HER2-negative Breast Cancer;   HER2-positive Breast Cancer;   Male Breast Cancer;   Ovarian Immature Teratoma;   Ovarian Mature Teratoma;   Ovarian Monodermal and Highly Specialized Teratoma;   Progesterone Receptor-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Recurrent Colon Cancer;   Recurrent Extragonadal Germ Cell Tumor;   Recurrent Extragonadal Non-seminomatous Germ Cell Tumor;   Recurrent Extragonadal Seminoma;   Recurrent Malignant Testicular Germ Cell Tumor;   Recurrent Melanoma;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Rectal Cancer;   Stage III Extragonadal Non-seminomatous Germ Cell Tumor;   Stage III Extragonadal Seminoma;   Stage III Malignant Testicular Germ Cell Tumor;   Stage III Ovarian Germ Cell Tumor;   Stage IV Breast Cancer;   Stage IV Colon Cancer;   Stage IV Extragonadal Non-seminomatous Germ Cell Tumor;   Stage IV Extragonadal Seminoma;   Stage IV Melanoma;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Rectal Cancer;   Testicular Immature Teratoma;   Testicular Mature Teratoma
Interventions: Drug: PD-0332991;   Other: pharmacological study
2 Recruiting DNA Analysis of Tumor Tissue Samples From Patients With Recurrent or Metastatic Breast Cancer That Expresses HER2
Condition: Breast Cancer
Interventions: Genetic: comparative genomic hybridization;   Genetic: fluorescence in situ hybridization;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: biopsy;   Procedure: histopathologic examination
3 Recruiting OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
Condition: Cancer
Interventions: Genetic: protein expression analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: biopsy
4 Recruiting Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Condition: Breast Cancer
Interventions: Biological: bevacizumab;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: paclitaxel
5 Recruiting Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
Conditions: Breast Cancer;   Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Prostate Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Interventions: Genetic: gene expression analysis;   Genetic: gene rearrangement analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Radiation: radiation therapy
6 Recruiting Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
Conditions: Breast Cancer;   Metastatic Cancer;   Multiple Myeloma and Plasma Cell Neoplasm;   Musculoskeletal Complications;   Pain;   Prostate Cancer;   Urinary Complications
Intervention: Drug: zoledronic acid
7 Recruiting F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer
Conditions: Breast Cancer;   Palmar-Plantar Erythrodysesthesia
Interventions: Drug: antiperspirant cream F511;   Drug: pegylated liposomal doxorubicin hydrochloride
8 Recruiting AZD0530 in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery
Condition: Breast Cancer
Interventions: Drug: AZD0530;   Other: immunoenzyme technique;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Other: spectrometry
9 Recruiting Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: lapatinib ditosylate;   Genetic: TdT-mediated dUTP nick end labeling assay;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Other: immunohistochemistry staining method;   Procedure: biopsy;   Procedure: fine-needle aspiration;   Radiation: radiation therapy
10 Recruiting Paclitaxel and Trastuzumab and/or Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
Condition: Breast Cancer
Interventions: Biological: trastuzumab;   Drug: lapatinib ditosylate;   Drug: paclitaxel
11 Recruiting Tamoxifen Citrate in Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: tamoxifen citrate;   Other: laboratory biomarker analysis;   Other: pharmacological study
12 Recruiting Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer
Conditions: Breast Cancer;   Colorectal Cancer;   Lung Cancer;   Melanoma (Skin);   Pancreatic Cancer
Interventions: Genetic: protein analysis;   Genetic: proteomic profiling;   Other: laboratory biomarker analysis
13 Recruiting Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
Condition: Breast Cancer
Interventions: Biological: bevacizumab;   Drug: cyclophosphamide;   Drug: paclitaxel;   Drug: pegylated liposomal doxorubicin hydrochloride;   Other: placebo
14 Recruiting Study of Genes and Environment in Patients With Breast Cancer in the East Anglia Region of the United Kingdom
Condition: Breast Cancer
Interventions: Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration
15 Recruiting Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Conditions: Breast Cancer;   Lung Cancer;   Metastatic Cancer;   Multiple Myeloma and Plasma Cell Neoplasm;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Procedure: assessment of therapy complications
16 Recruiting Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2
Condition: Breast Cancer
Interventions: Biological: HER-2/neu intracellular domain protein;   Other: flow cytometry;   Other: immunohistochemistry staining method;   Other: immunological diagnostic method;   Other: laboratory biomarker analysis;   Procedure: biopsy
17 Recruiting Dasatinib in Treating Patients With Stage IV Breast Cancer That Has Spread to the Bone
Conditions: Breast Cancer;   Metastatic Cancer
Intervention: Drug: dasatinib
18 Recruiting Study of Individuals and Families at High Risk for Breast or Ovarian Cancer
Conditions: Breast Cancer;   Hereditary Breast/Ovarian Cancer (brca1, brca2);   Ovarian Cancer
Interventions: Genetic: gene mapping;   Genetic: mutation analysis;   Other: questionnaire administration;   Procedure: biopsy;   Procedure: breast duct lavage;   Procedure: breast imaging study;   Procedure: magnetic resonance imaging;   Procedure: radiomammography;   Procedure: study of high risk factors
19 Recruiting Bicalutamide in Treating Patients With Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: bicalutamide;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
20 Recruiting Acupuncture and Moxibustion in Improving Well-Being and Quality of Life in Patients With Breast Cancer or Head, Neck, and Throat Cancer Who Are Undergoing Standard Treatment for Lymphedema
Conditions: Breast Cancer;   Head and Neck Cancer;   Lymphedema
Interventions: Other: questionnaire administration;   Procedure: acupuncture therapy;   Procedure: assessment of therapy complications;   Procedure: management of therapy complications;   Procedure: naturopathy therapy;   Procedure: quality-of-life assessment

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services